NIFTY 50▼25,084.70
-165.40 (-0.66%)
SENSEX▼81,945.35
-551.75 (-0.67%)
NIFTY BANK▼51,680.25
-164.95 (-0.32%)
TATA MOTORS▲929.25
3.55 (0.38%)
SUZLON ENERGY▼74.68
-1.07 (-1.41%)
TATA STEEL▲167.11
0.13 (0.08%)
INDIAN RAILWAY FINANCE CORP▼150.80
-0.80 (-0.53%)
TATA POWER▼467.45
-4.35 (-0.92%)
RAIL VIKAS NIGAM▼495.40
-14.10 (-2.77%)
VODAFONE IDEA▲9.88
0.01 (0.10%)
RELIANCE INDUSTRIES▼2,784.70
-29.25 (-1.04%)
INDIAN RENEWABLE ENERGY▼221.98
-1.34 (-0.60%)
ZOMATO▲275.30
6.30 (2.34%)
RELIANCE POWER▼50.95
-2.69 (-5.01%)
ADANI POWER▼640.60
-4.15 (-0.64%)
YES BANK▲21.99
0.13 (0.59%)
STATE BANK OF INDIA▲795.45
1.35 (0.17%)
NHPC▼92.74
-0.22 (-0.24%)
HDFC BANK▼1,662.55
-19.45 (-1.16%)
JIO FIN SERVICES LTD▼341.25
-4.35 (-1.26%)
OLA ELECTRIC MOBILITY LTD▼98.77
-0.49 (-0.49%)
BHARAT ELECTRONICS▼277.50
-1.20 (-0.43%)
ADANI PORT & SEZ▼1,416.85
-8.35 (-0.59%)
INDIAN OIL CORP▼168.30
-3.03 (-1.77%)
GTL INFRA▼2.33
-0.02 (-0.85%)
MRF▼1,34,150.00
-1954.35 (-1.44%)
INDIAN RAILWAY TOURISM CORP▼878.00
-8.40 (-0.95%)
JAIPRAKASH POWER VENTURES▼19.60
-0.50 (-2.49%)
  1. home
    apple-store
  2. stocks
    apple-store
  3. stocks list
    apple-store
  4. BAFNA PHARMA
stock logo

BAFNA PHARMA Share Price

BAFNAPH

₹82.99-₹2.95 (-3.43%) TodayLast updated on 04 Oct, 2024 | 13:23 IST
Please wait...

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹203 Crs

Open

₹81.64

Close

₹85.94

Circuit range

₹90.23 - ₹81.64

Day range

₹81.64 - ₹85.97

Year range

₹73.25 - ₹113.00

Volume

1,498

Avg. traded

₹83.34

Revenue (12m)

₹144 Crs

BAFNA PHARMABafna Pharmaceuticals Limited is an India-based company, which is engaged in the manufacture of drugs and medicines and selling a reputed brand namely RARICAP. The Company caters to both domestic and international market. It operates in generic pharmaceutical segment. The Company manufactures 336 licensed pharmaceutical formulations and have globally registered 78 of its products. It supplies its products to the United Kingdom, Europe, and Australian markets. The Company's Grantlyon facility has the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. The Company’s subsidiary is Bafna Lifestyles Remedies Limited.

BAFNA PHARMA Key indicators

arrow

52 week high

₹113.00

52 week low

₹73.25

P/E ratio

741.44

P/B ratio

ROE

9.52%

ROCE

9.56%

Dividend yield

--

Debt/Equity ratio

0.3

EPS

3.11

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow

  • Profitability

  • Operational

  • Valuation

Operating profit margin

9.6%

Net profit margin

4.82%

ROE

9.52%

ROA

5.3%

ROCE

9.56%

Learn more

BAFNA PHARMA Shareholder returns

arrow

1 day

+2.66%

1 week

+1.46%

1 month

+3.36%

3 months

-1.63%

1 year

-2.01%

3 years

-32.68%

5 years

+1768.26%

BAFNA PHARMA Share Price history

arrow
DayOpenCloseDay’s change
Thu, Oct 3 2024
₹84.00
₹85.94
+2.66%
Tue, Oct 1 2024
₹87.70
₹83.71
-1.51%
Mon, Sep 30 2024
₹84.00
₹84.99
-2.84%
Fri, Sep 27 2024
₹84.00
₹87.47
+4.26%
Thu, Sep 26 2024
₹87.95
₹83.90
-0.94%
Wed, Sep 25 2024
₹85.00
₹84.70
+1.95%
Tue, Sep 24 2024
₹83.30
₹83.08
+2.66%
Mon, Sep 23 2024
₹80.93
₹80.93
+4.99%

Shareholding info

arrow

Promoters (88.3%)

Mutual Funds (0%)

Retail and other (11.7%)

Foreign institutions-FII (0%)

Other domestic institutions (0%)

Promoters

Learn more

Events

Corporate actions

arrow

  • Rights Issue • 0:0

    Ex date

    expand tab

Learn more

Frequently asked questions